当在瘤学试验中不理想的治疗后护理得到奖励时
Giuseppe Salfi1, Timothée Olivier2
1Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland; Institute of Oncology Research (IOR), Bellinzona, Switzerland.
概括
在瘤学试验中,非最佳的治疗后护理可能会错误地增加存活率. 评估协议后数据对于准确的整体存活率解释和公平的药物监管至关重要.
科学领域:
- 瘤学 临床试验 临床试验
- 监管科学 监管科学
- 基于证据的医学 基于证据的医学
背景情况:
- 总生存率 (OS) 是瘤药物批准和治疗指南的主要终点.
- 对控制臂进行不充分的治疗后护理可以人工膨胀生存优势.
- 这一问题影响了各种癌症类型和治疗环境中的试验解释.
研究的目的:
- 要突出如何低于最佳的协议后护理可以扭曲瘤学试验中的生存结果.
- 检查这种扭曲对监管优势和指导方针建议的影响.
- 为在临床试验设计和审查中系统评估治疗后护理提出解决方案.
主要方法:
- 分析了三项瘤学试验实例 (黑色素瘤,乳腺癌,泌尿器癌) 的分析,这些实验中治疗后的护理水平低于最佳水平.
- 检查当前的监管和指南系统如何通过明显的生存增长来奖励试验.
- 关于将协议后数据纳入试验评估和监管咨询的建议.
主要成果:
- 在各种瘤学环境中,不充分的治疗后护理被确定为明显的生存优势的潜在贡献者.
- 目前的系统可能无意中偏好了扭曲的生存数据的试验.
- 显而易见的生存增长可能会导致不合理的监管优势或更强的指导方针建议.
结论:
- 术后数据必须是评估瘤学试验生存结果的核心组成部分.
- 在提交前的监管商中,系统地考虑协议后护理是必不可少的.
- 确保最佳的试验后护理对于试验结果的概括性和明智的药物授权至关重要.
相关概念视频
Nursing Ethical Principles II
1.3K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.3K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Clinical Trials
8.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.3K
Standards of Care II
725
Nurses bear specific legal responsibilities under several federal statutes, including:
725


